⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for cd52

Every month we try and update this database with for cd52 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic LeukemiaNCT01982175
B-cell Chronic ...
Alemtuzumab
18 Years - 75 YearsShanghai Zhangjiang Biotechnology Limited Company
Campath-1H for Treating Adult T-Cell Leukemia/LymphomaNCT00061048
Acute T-Cell Le...
Alemtuzumab
18 Years - National Institutes of Health Clinical Center (CC)
Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic LeukemiaNCT01982175
B-cell Chronic ...
Alemtuzumab
18 Years - 75 YearsShanghai Zhangjiang Biotechnology Limited Company
Phase II Clinical Trial of Alemtuzumab to Treat B-cell Chronic Lymphocytic LeukemiaNCT01982175
B-cell Chronic ...
Alemtuzumab
18 Years - 75 YearsShanghai Zhangjiang Biotechnology Limited Company
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: